Showing results (41-50 of 84) with videos related to
Sort By:
Pageof 9
Cell Biochemistry and Function|February 3, 2011
Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cellsZhiwei Chen, Xiaomin Niu, Ziming Li, et al.Mutagenesis|March 16, 2011
The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studiesZhiwei Chen, Ziming Li, Xiaomin Niu, et al.Cellular Immunology|July 23, 2022
FGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 expression upregulation in lung squamous cell carcinomaMin Lu, Kaixuan Wang, Wenxiang Ji, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 18, 2023
EptA of Riemerella anatipestifer mediates phenotypes involved in colistin resistance and virulenceQiwei Chen, Heng Quan, Yongfeng Yu, et al.Journal of Cancer Research and Clinical Oncology|April 25, 2012
EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinomaYongfeng Yu, Zhengbo Song, Hui Gao, et al.Oncotarget|March 4, 2016
FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathwayWenxiang Ji, Yongfeng Yu, Ziming Li, et al.Oncogene|June 3, 2018
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancerKaixuan Wang, Wenxiang Ji, Yongfeng Yu, et al.Lung Cancer (Amsterdam, Netherlands)|September 18, 2022
Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapyMengxiao Wang, Huayan Huang, Zhangwendi Xu, et al.Translational Lung Cancer Research|July 8, 2024
Prominent response to savolitinib monotherapy in high-grade fetal adenocarcinoma with <i>MET</i> amplification and concurrent brain metastasis: a case reportLan Shen, Jikai Zhao, Ying Yang, et al.Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Concomitant resistance mechanisms to multiple tyrosine kinase inhibitors in ALK-positive non-small cell lung cancerYongfeng Yu, Qiuxiang Ou, Xue Wu, et al.Pageof 9